Mg. Thompson et al., ARACHIDONATE ACTIVATION OF PROTEIN-KINASE-C MAY BE INVOLVED IN THE STIMULATION OF PROTEIN-SYNTHESIS BY INSULIN IN L6 MYOBLASTS, Bioscience reports, 13(6), 1993, pp. 359-366
Insulin stimulated protein synthesis in L6 myoblasts but did not incre
ase the labelling of DAG or the release of phosphocholine from phospha
tidylcholine. The DAG lipase inhibitor, RHC 80267, more than doubled t
he amount of label appearing in DAG but did not stimulate protein synt
hesis. Even in the presence of the DAG lipase inhibitor insulin failed
to have any effect on DAG labelling, and conversely RHC 80267 did not
modify the insulin-induced increase in protein synthesis. These resul
ts suggest that endogenous DAG production is not involved in the stimu
lation of,protein synthesis by insulin. However, exogenous diacylglyce
rols (1-oleoyl-2-acetyl glycerol and 1-stearoyl-2-arachidonoyl glycero
l) both stimulated protein synthesis in L6 myoblasts. The efficacy of
the former (arachidonate-free) DAG suggested that their action was by
activation of protein kinase C rather than by arachidonate release and
prostaglandin formation. Ibuprofen, an inhibitor of cyclo-oxygenase f
ailed to block the effects of insulin whereas a second cyclo-oxygenase
inhibitor, indomethacin had only a partial inhibitory effect. The pro
tein kinase C (PKC) inhibitor, RO-31-8220, totally blocked the effect
of insulin. Since indomethacin is also recognised to inhibit phospholi
pase A(2), the data suggests that insulin acts on protein synthesis in
myoblasts by arachidonate activation of PKC.